2011Chinese Journal of AsthmaRequires access

Evaluation of trend of thrombolysis rate in treatment of acute pulmonary embolism

Xia Zhang, Zhe Chen, Lixia Dong, Diansheng Zhong, Bao-yuan Chen

Open publisher page 0 citations

Abstract

Objective To compare therapeutic efficacy of thrombolysis and anticoagulation in acute pulmonary embolism,and to analyze the trend of thrombolysis rate. Methods The clinical data of 190patients with pulmonary embolism in our hospital were retrospectively analyzed. They were divided into thrombolysis group and anticoagulation group. The thrombolysis rate, effective rate, bleeding rate and recurrence rate were compared between two groups. Results The thrombolysis rates on the three stages 2001-2003 (A), 2004-2006(B), 2007-2009(C)were 45.7%, 31.3 %, 15.3 %, which gradually decreased.There was statistical significance between A,B and C (all P <0.05). There was no statistical significance on the effective rate between thrombolysis group (94.8%) and anticoagulation group (93.2%). The bleeding rate in thrombolysis group (10.3 %) was higher than that in anticoagulation group (2.3%) (P<0.05). There was no statistical significance on the recurrence rate between thrombolysis group (21.8%)and antieoagulation group (22.5 %). Conclusions The proportion of thrombolytic therapy in pulmonary embolism tends to decrease. Compared with anticoagulant therapy, thrombolytic therapy has similar effects, can not reduce the recurrence rate,and has a higher bleeding risk. Anticoagulant therapy is safe and effective. Key words: Pulmonary embolism;  Thrombolytic therapy;  Anticoagulant therapy;  Effectiveness

About this research paper

What this paper is about

Objective To compare therapeutic efficacy of thrombolysis and anticoagulation in acute pulmonary embolism,and to analyze the trend of thrombolysis rate. Methods The clinical data of 190patients with pulmonary embolism in our hospital were retrospectively analyzed. They were divided into thrombolysis group and anticoagulation group. The thrombolysis rate, effective rate, bleeding rate and recurrence rate were compared between two groups. Results The thrombolysis rates on the three stages 2001-2003 (A), 2004-2006(B), 2007-2009(C)were 45.7%, 31.3 %, 15.3 %, which gradually decreased.There was statistical significance between A,B and C (all P <0.05). There was no statistical significance on the effective rate between thrombolysis group (94.8%) and anticoagulation group (93.2%). The bleeding rate in thrombolysis group (10.3 %) was higher than that in anticoagulation group (2.3%) (P<0.05). There was no statistical significance on the recurrence rate between thrombolysis group (21.8%)and antieoagulation group (22.5 %). Conclusions The proportion of thrombolytic therapy in pulmonary embolism tends to decrease. Compared with anticoagulant therapy, thrombolytic therapy has similar effects, can not reduce the recurrence rate,and has a higher bleeding risk. Anticoagulant therapy is safe and effective. Key words: Pulmonary embolism;  Thrombolytic therapy;  Anticoagulant therapy;  Effectiveness

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare therapeutic efficacy of thrombolysis and anticoagulation in acute pulmonary embolism,and to analyze the trend of thrombolysis rate. Methods The clinical data of 190patients with pulmonary embolism in our hospital were retrospectively analyzed. They were divided into thrombolysis group and anticoagulation group. The thrombolysis rate, effective rate, bleeding rate and recurrence rate were compared between two groups. Results The thrombolysis rates on the three stages 2001-2003 (A), 2004-2006(B), 2007-2009(C)were 45.7%, 31.3 %, 15.3 %, which gradually decreased.There was statistical significance between A,B and C (all P <0.05). There was no statistical significance on the effective rate between thrombolysis group (94.8%) and anticoagulation group (93.2%). The bleeding rate in thrombolysis group (10.3 %) was higher than that in anticoagulation group (2.3%) (P<0.05). There was no statistical significance on the recurrence rate between thrombolysis group (21.8%)and antieoagulation group (22.5 %). Conclusions The proportion of thrombolytic therapy in pulmonary embolism tends to decrease. Compared with anticoagulant therapy, thrombolytic therapy has similar effects, can not reduce the recurrence rate,and has a higher bleeding risk. Anticoagulant therapy is safe and effective. Key words: Pulmonary embolism;  Thrombolytic therapy;  Anticoagulant therapy;  Effectiveness

Key concepts: Thrombolysis, Medicine, Pulmonary embolism, Statistical significance, Anticoagulant therapy, Internal medicine, Cardiology, Myocardial infarction

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of trend of thrombolysis rate in treatment of acute pulmonary embolism — Research Paper | ScholarLens